|
Most read Oncology news in the past 7 days
Papers and articles, pertaining to Oncology, most read by your
colleagues in the past 7 days
Cetuximab and irinotecan as third-line therapy in advanced colorectal
cancer patients: a single centre phase II trial (Br J Cancer)
Docetaxel and gemcitabine combination in 133 advanced soft-tissue
sarcomas: A retrospective analysis (Int J Cancer)
Angiogenesis modifications related with cetuximab plus irinotecan as
anticancer treatment in advanced colorectal cancer patients (Ann
Oncol)
Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in
combination with gemcitabine and carboplatin in patients with
advanced non-small cell lung cancer (Lung Cancer Online)
Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant
metastatic pancreatic cancer (Br J Cancer)
Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium
folinate in metastatic gastrointestinal cancer patients: original
analysis of non-hematological toxicity and patient characteristics in
a pilot investigation (Int J Clin Pharmacol ther)
Glucocorticoids interfere with therapeutic efficacy of paclitaxel
against human breast and ovarian xenograft tumors (Int J Cancer)
Irinotecan/5-fluorouracil combination induces alterations in
mitochondrial membrane potential and caspases on colon cancer cell
lines (Oncol Res)
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in
patients aged 60 plus with aggressive non-Hodgkin's lymphoma (Br J
Cancer)
Optimizing the use of aromatase inhibitors in adjuvant therapy for
postmenopausal patients with hormone-responsive early breast cancer:
current and future prospects (J Cancer Res Clin Oncol)
More news...
|